Heart Disease News and Research

Latest Heart Disease News and Research

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

23 Jun 2010

Study investigates benefits of filtering blood to create safer approaches to transfusion therapy

Researchers at the University of Rochester Medical Center have discovered yet another reason to filter the foreign white cells from donor blood: The resulting blood product is associated with dramatically fewer cardiopulmonary complications for patients who received a transfusion.

23 Jun 2010

FDA approves Hospira's meropenem for injection, USP (I.V.)

Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V.) 500 mg and 1 g vials. The medication, a carbapenem that belongs to the beta-lactam class of antibiotics, is a generic version of AstraZeneca's Merrem® I.V. Sales of the name-brand product in the United States were approximately $200 million in 2009.

23 Jun 2010

Nuon study confirms potential utility of tranilast as uricosuric agent

Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that results from clinical and preclinical studies demonstrating the ability of tranilast to reduce serum uric acid levels and monosodium urate crystal-induced inflammation - two important risk factors for gout - were presented at The European League Against Rheumatism (EULAR) 2010 Annual European Congress of Rheumatology in Rome, Italy, June 16-19, 2010.

22 Jun 2010

Fructose makes cells mature into fat cells in belly fat, study finds

Fructose, the sugar widely used as high-fructose corn syrup in soft drinks and processed foods, often gets some of the blame for the widespread rise in obesity. Now a laboratory study has found that when fructose is present as children's fat cells mature, it makes more of these cells mature into fat cells in belly fat and less able to respond to insulin in both belly fat and fat located below the skin.

22 Jun 2010

Three leading scientists gather to discuss Improved Strategies for Pre-clinical Cardiac Testing

Three leading scientists in the field of cardiac safety in pre-clinical drug development are gathering to discuss Improved Strategies for Pre-clinical Cardiac Testing in a free webinar on June 23 at 11:00 a.m. EDT, sponsored by the Drug Safety Council.

22 Jun 2010

Beneficial effects of LifeVantage's Protandim on DMD mouse model published in Journal of Dietary Supplements

LifeVantage Corporation, the maker of Protandim®, a patented, science-based solution to oxidative stress, announced today that a peer-reviewed manuscript was published in the Journal of Dietary Supplements examining the beneficial effects of Protandim® on a mouse model of Duchenne Muscular Dystrophy (DMD), an X-linked inherited disease affecting one in 3,500 males.

22 Jun 2010

Nature Rocks, American Heart Association encourage increased physical activity among all Americans

Today Nature Rocks, a national program created to inspire and empower parents to take their families to play, explore and enjoy quality time in nature, announced a collaboration with the American Heart Association's Start! Initiative. Start! encourages increased physical activity among all Americans, emphasizing walking because it's easy, free and has the lowest dropout rate of any form of activity.

22 Jun 2010

Cardiogenesis' shares quoted on newly launched OTCQB market

Cardiogenesis Corporation today announced that its shares are now being quoted on the newly launched OTCQB market. Launched in April 2010, the OTCQB is a new market tier for OTC-traded U.S. companies that are registered and reporting with the Securities and Exchange Commission.

22 Jun 2010

NIH, Wellcome Trust partner to support population-based genetic studies of disorders, communicable diseases in Africa

The National Institutes of Health, an agency of the U.S. Department of Health and Human Services, and the Wellcome Trust, a global charity based in London, today announced a partnership to support population-based genetic studies in Africa of common, non-communicable disorders such as heart disease and cancer, as well as communicable diseases such as malaria.

22 Jun 2010

Regulus Therapeutics, sanofi-aventis partner to develop and commercialize microRNA therapeutics

Regulus Therapeutics Inc. and sanofi-aventis announced today that they have entered into a global, strategic alliance to discover, develop, and commercialize microRNA therapeutics. The alliance represents the largest microRNA partnership formed to date, valued at potentially over $750 million, and includes a $25 million upfront fee, a $10 million future equity investment subject to mutual agreement on company valuation, and annual research support for three years with the option to extend two additional years.

22 Jun 2010

Metabolic syndrome can negatively affect donor's kidney function outcome, study finds

People who donate one of their kidneys experience faster deterioration of their other kidney if they have the metabolic syndrome at the time of donation, a new study finds. The results will be presented Sunday at The Endocrine Society's 92nd Annual Meeting in San Diego.

22 Jun 2010

Improving health care for Saskatchewan patients remains a challenge: HQC report

In October 2008 the province's Health Quality Council released its first "state of health care quality" report, called Quality Insight. Key messages in that inaugural report were that limited access to timely data and the absence of an electronic health record were making it hard for HQC, health providers, and system leaders to improve health care for Saskatchewan patients.

22 Jun 2010

Insurance cover in "passive war" environment saves reforestation expert

Conflicts and wars not only take their toll on human lives, but also on the local environment. Whilst much publicity is focused on International efforts to help rebuild Afghanistan's economy and social structures, less well known is the - often voluntary - work going on to rebuild the environment, part of which involves the planting of millions of trees, as a more green environment helps to improve the dusty landscape damaged by years of fighting. More greenery also means cleaner air.

22 Jun 2010

Gardner Family Health Network to deploy NextGen Ambulatory EHR, Practice Management, QSI Dental System

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, today announced an agreement with Gardner Family Health Network to deploy NextGen® Ambulatory EHR and NextGen® Practice Management, as well as the QSI Dental System. Gardner is the 42nd health center in California to partner with NextGen Healthcare.

22 Jun 2010

Six Rio South Texas hospitals among nation's top 5%

Successful regional economic development has to focus on more than tax incentives, skilled labor pools and transportation infrastructure. In considering possible locations for starting or expanding operations, corporations look closely at quality of life issues such as the availability of excellent healthcare. And Rio South Texas has a healthy quality of life outlook, with six of the nation's safest hospitals among its offerings.

22 Jun 2010

Cytochrome P450 plays important role in management of high blood pressure: Researchers

Researchers have found that increasing certain proteins in the blood vessels of mice, relaxed the vessels, lowering the animal's blood pressure. The study provides new avenues for research that may lead to new treatments for hypertension.

22 Jun 2010

Novel MC4R agonist exhibits potential as new treatment for obesity, diabetes

Rhythm, a biotechnology company developing peptide therapeutics for metabolic diseases, today announced a study of obese primates treated with RM-493 showing a reversal of obesity and insulin resistance, and improvement in both heart rate and blood pressure. RM-493 is a novel peptide agonist targeting the melanocortin 4 receptor (MC4R) that is a clinical candidate for the treatment of obesity and diabetes.

22 Jun 2010

Chocolate bar with resveratrol may help improve memory, learning skills

Wondering where you put the car keys? Can't remember what day of the week it is? Perhaps you need to eat a new kind of chocolate bar.

22 Jun 2010

SYMPLICITY HTN-1 study: RDN treatment significantly reduces blood pressure

Long-term data presented today from Ardian's SYMPLICITY HTN-1 study demonstrate that the significant reductions in blood pressure achieved using Renal Denervation treatment are sustained through 24 months. The data were presented at the late breaking trials session of the European Society of Hypertension Annual Scientific meeting in Oslo, Norway.

22 Jun 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Study investigates benefits of filtering blood to create safer approaches to transfusion therapy

FDA approves Hospira's meropenem for injection, USP (I.V.)

Nuon study confirms potential utility of tranilast as uricosuric agent

Fructose makes cells mature into fat cells in belly fat, study finds

Three leading scientists gather to discuss Improved Strategies for Pre-clinical Cardiac Testing

Beneficial effects of LifeVantage's Protandim on DMD mouse model published in Journal of Dietary Supplements

Nature Rocks, American Heart Association encourage increased physical activity among all Americans

Cardiogenesis' shares quoted on newly launched OTCQB market

NIH, Wellcome Trust partner to support population-based genetic studies of disorders, communicable diseases in Africa

Regulus Therapeutics, sanofi-aventis partner to develop and commercialize microRNA therapeutics

Metabolic syndrome can negatively affect donor's kidney function outcome, study finds

Improving health care for Saskatchewan patients remains a challenge: HQC report

Insurance cover in "passive war" environment saves reforestation expert

Gardner Family Health Network to deploy NextGen Ambulatory EHR, Practice Management, QSI Dental System

Six Rio South Texas hospitals among nation's top 5%

Cytochrome P450 plays important role in management of high blood pressure: Researchers

Novel MC4R agonist exhibits potential as new treatment for obesity, diabetes

Chocolate bar with resveratrol may help improve memory, learning skills

SYMPLICITY HTN-1 study: RDN treatment significantly reduces blood pressure

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in